Article PubMed Google Scholar Download references Competing Interests R.J.F.L
The GLP-1 (treatment) cohort was comprised of individuals who (i) had no prior history of GLP-1 use, (ii) initiated GLP-1 medications from January 2019 onwards with the prescription originating from a primary care provider or endocrinologist, and (iii) had medication orders indicating a minimum duration of 12 months of prescriptions
An in vitro study utilizing cultured B16 melanoma cells found that while PYC suppressed reactive species in their assays, glutathione was enhanced (Kim et al., 2008)
3 for a plate diagram of the solution arrangement
Beyond Basal Insulin When treatment is intensified beyond basal insulin therapy, a number of factors should be taken into account as part of the shared decision-making process, such as patient preference, safety, tolerability, glycemic efficacy, risk of hypoglycemia, and other non-glycemic effects (e.g., weight change and/or impact on life-style) [13]
Berlanda N, Somigliana E, Vigan P, Vercellini P
